Fulcrum Therapeutics (FULC) Receivables - Other (2020 - 2025)

Fulcrum Therapeutics (FULC) has 6 years of Receivables - Other data on record, last reported at $979000.0 in Q1 2025.

  • On a quarterly basis, Receivables - Other changed N/A to $979000.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $979000.0, a N/A change, with the full-year FY2024 number at $2.1 million, up 290.32% from a year prior.
  • Receivables - Other reached $979000.0 in Q1 2025 per FULC's latest filing, down from $2.1 million in the prior quarter.
  • Over the last five years, Receivables - Other for FULC hit a ceiling of $3.7 million in Q3 2024 and a floor of $99000.0 in Q1 2023.
  • A 5-year average of $986200.0 and a median of $656000.0 in 2023 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: plummeted 87.66% in 2023, then soared 530.34% in 2024.
  • Tracing FULC's Receivables - Other over 5 years: stood at $1.1 million in 2021, then plummeted by 79.86% to $229000.0 in 2022, then soared by 134.5% to $537000.0 in 2023, then skyrocketed by 290.32% to $2.1 million in 2024, then tumbled by 53.29% to $979000.0 in 2025.
  • Business Quant data shows Receivables - Other for FULC at $979000.0 in Q1 2025, $2.1 million in Q4 2024, and $3.7 million in Q3 2024.